Trial of X4P-001 in Participants With Advanced Renal Cell Carcinoma

NCT02667886 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

74

Enrollment

INDUSTRY

Sponsor class

Conditions

Clear Cell Renal Cell Carcinoma

Interventions

DRUG: X4P-001
DRUG: axitinib

Sponsor

X4 Pharmaceuticals